1. Guidelines of the food and drug administration for study of new drugs in human subjects;Crout JR;Ann Intern Med,1978
2. U.S. Food & Drug Administration.Developing Products For Rare Diseases & Conditions.https://www.fda.gov/industry/developing‐products‐rare‐disease‐conditions. Accessed March 13 2022.
3. U.S. Department of Health and Human Services Food and Drug Administration CBER.Human gene therapy for rare diseases. Guidance for Industry.2020.
4. Rare disease, orphan drugs, and their regulation in Asia: current status and future perspective;Song P;Intractable Rare Dis Research,2012
5. U.S. Department of Health and Human Services Food and Drug Administration Office of Orphan Products development (OOPD).Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations of Common Diseases: Guidance for Industry.2018.